Brief: Sprint Bioscience Secures Bridge Financing Of SEK 12 Mln
Dec 11 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* SIGNS DEAL REGARDING BRIDGE FINANCING OF 12 MSEK
* FINANCING RUNS UNTIL END OF FEBRUARY 2019 WITH OPTION TO EXTEND UNTIL END OF MARCH 2019
Source text for Eikon: ID:nWkr4rGDqz
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln